olanzapine
olanzapine.JPG

CLINICAL USE

Schizophrenia Moderate to severe mania

DOSE IN NORMAL RENAL FUNCTION

Oral: 5–20 mg daily IM: 5–10 mg repeated after 2 hours if required; maximum 3 doses daily for 3 daysMaximum dose of combined routes: 20 mg per day

PHARMACOKINETICS

  • Molecular weight                           :312.4
  • %Protein binding                           :93
  • %Excreted unchanged in urine     : 7 (57% as metabolites and unchanged drug)
  • Volume of distribution (L/kg)       :
  • 10 to 20     :
  • half-life – normal/ESRD (hrs)      :30–38/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Initial dose 5 mg daily and titrate as necessary
  • 10 to 20     : Initial dose 5 mg daily and titrate as necessary
  • <10           : Initial dose 5 mg daily and titrate as necessary

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in GFR <10 mL/min
  • HD                     :Not dialysed. Dose as in GFR <10 mL/min
  • HDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/min
  • CAV/VVHD      :Unknown dialysability. Dose as in GFR 10 to 20 mL/min

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Anaesthetics: enhanced hypotensive effect
  • Analgesics: increased risk of convulsions with tramadol; enhanced hypotensive and sedative effects with opioids
  • Antibacterials: concentration possibly increased by ciprofloxacin
  • Antidepressants: fluvoxamine increases concentration of olanzapine
  • Anti-epileptics: antagonism (convulsive threshold lowered); carbamazepine increases metabolism of olanzapine; increased risk of neutropenia with valproate
  • Antimalarials: avoid concomitant use with artemether/lumefantrine
  • Antivirals: concentration reduced by ritonavirAnxiolytics and hypnotics: increased sedative effects; increased risk of hypotension, bradycardia and respiratory depression with IM olanzapine and parenteral benzodiazepines
  • Sibutramine: increased risk of CNS toxicity – avoid concomitant use

    ADMINISTRATION

    Reconstition

    2.1 mL water for injection

    Route

    Oral, IM

    Rate of Administration

    Comments

    –.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs